SEARCH

SEARCH BY CITATION

References

  • Aricò, M., Schrappe, M., Hunger, S.P., Carroll, W.L., Conter, V., Galimberti, S., Manabe, A., Saha, V., Baruchel, A., Vettenranta, K., Horibe, K., Benoit, Y., Pieters, R., Escherich, G., Silverman, L.B., Pui, C.H. & Valsecchi, M.G. (2010) Clinical outcome of children with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukaemia treated between 1995 and 2005. Journal of Clinical Oncology, 28, 47554761.
  • Biondi, A., Schrappe, M., De Lorenzo, P., Castor, A., Lucchini, G., Gandemer, V., Pieters, R., Stary, J., Escherich, G., Campbell, M., Li, C.K., Vora, A., Aricò, M., Röttgers, S., Saha, V. & Valsecchi, M.G. (2012) Imatinib after induction for treatment of children and adolescents with Philadelphia-chromosome-positive acute lymphoblastic leukaemia (EsPhALL): a randomised, open-label, intergroup study. The Lancet Oncology, 13, 936945.
  • Nishiwaki, S., Miyamura, K., Kato, C., Terakura, S., Ohashi, K., Sakamaki, H., Nakao, S., Harigae, H. & Kodera, Y. (2010) Impact of post-transplant imatinib administration on Philadelphia chromosome-positive acute lymphoblastic leukaemia. Anticancer Research, 30, 24152418.
  • Pfeifer, H., Wassmann, B., Bethge, W., Dengler, J., Bornhauser, M. & Stadler, M. (2011) Updated long-term results of a randomized comparison of prophylactic and pre-emptive imatinib following allogeneic stem cell transplantation for Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL). Blood (ASH Annual Meeting Abstracts), 118, 247.
  • Ribera, J.M., Oriol, A., González, M., Vidriales, B., Brunet, S., Esteve, J., Del Potro, E., Rivas, C., Moreno, M.J., Tormo, M., Martín-Reina, V., Sarrá, J., Parody, R., Pérez de Oteyza, J., Bureo, E., Bernal, M.T. & Grupo Español de Trasplante Hemopoyético Groups. (2010) Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Final results of the CSTIBES02 trial. Haematologica, 95, 8795.
  • Rives, S., Estella, J., Gómez, P., López-Duarte, M., García de Miguel, P., Verdeguer, A., Moreno, M.J., Vivanco, J.L., Couselo, J.M., Fernández-Delgado, R., Maldonado, M., Tasso, M., López-Ibor, B., Lendínez, F., López-Almaraz, R., Uriz, J., Melo, M., Fernández-Teijeiro, A., Rodríguez, I. & Badell, I. (2011) Intermediate dose of imatinib in combination with chemotherapy followed by allogeneic stem cell transplantation improves early outcome in paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia (ALL): results of the Spanish Cooperative Group SHOP studies ALL-94, ALL-99 and ALL-2005. British Journal of Haematology, 154, 600611.
  • Schultz, K.R., Bowman, W.P., Aledo, A., Slayton, W.B., Sather, H., Devidas, M., Wang, C., Davies, S.M., Gaynon, P.S., Trigg, M., Rutledge, R., Burden, L., Jorstad, D., Carroll, A., Heerema, N.A., Winick, N., Borowitz, M.J., Hunger, S.P., Carroll, W.L. & Camitta, B. (2009) Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a Children's Oncology Group study. Journal of Clinical Oncology, 27, 51755181.
  • Thomas, D. (2012) Childhood Philadelphia-chromosome-positive B-lymphoblastic leukaemia. The Lancet Oncology, 13, 860862.